Stuttgart - Delayed Quote EUR

Reckitt Benckiser Group PLC (3RB.SG)

56.72

-0.36

(-0.63%)

As of 8:05:28 AM GMT+2. Market Open.

Reckitt Benckiser Group (LON:RKT shareholders incur further losses as stock declines 9.7% this week, taking five-year losses to 10%

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

Simply Wall St. 5 days ago

RBGLY

RBGPF
Reckitt Benckiser Group (RBGLY) Upgraded to Strong Buy: Here's What You Should Know

Reckitt Benckiser Group (RBGLY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 6 days ago

RBGLY
M&A and IPOs Worth Billions Stalled in 24 Hours by Trade War

(Bloomberg) -- Billions of dollars worth of acquisitions and initial public offerings are on hold as Donald Trump’s trade war upends the global economy, twisting the knife into a dealmaking market that had already struggled to get going this year.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersLocal Governments Vie for Fired Federal WorkersMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesWhat Would ‘Transportation Abundance’ Look Like?Hochul

Bloomberg 11 days ago

BX

ROSE.L

KKR
Are You Looking for a Top Momentum Pick? Why Reckitt Benckiser Group PLC (RBGLY) is a Great Choice

Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks 18 days ago

RBGLY
With 84% institutional ownership, Reckitt Benckiser Group plc (LON:RKT) is a favorite amongst the big guns

Key Insights Institutions' substantial holdings in Reckitt Benckiser Group implies that they have significant influence...

Simply Wall St. 21 days ago

RBGLY

RBGPF
RFK Jr.’s Next Targets Are Companies Making Baby Formula

(Bloomberg) -- Health and Human Services Secretary Robert F. Kennedy Jr. is taking on baby formula products, the latest in his sweeping review of ingredients used in the US food supply.Most Read from BloombergThe Dark Prophet of Car-Clogged CitiesWashington, DC, Region Braces for ‘Devastating’ Cuts from CongressNYC Plans for Flood Protection Without Federal FundsA Malibu Model for Residents on the Fire FrontlinesDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleUnder Kennedy, the

Bloomberg 28 days ago

RBGLY

ABT
Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case

Reckitt described the re-opening of the trial as being “at complete odds with the law and the facts”.

Just Food 29 days ago

RBGLY

ABT
As trade war intensifies, Reckitt may be more exposed than some rivals

Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low manufacturing capacity there compared to some rivals leaves the company more exposed to new U.S. tariffs on imports from Mexico. Reckitt, which makes Lysol cleaning products and Durex condoms, has five factories in the United States. It told Reuters in early March that it manufactures about 57% of its U.S. sales volumes locally, with the other 43% coming from places including Mexico and Southeast Asia.

Reuters 30 days ago

RBGLY

HLN
Citi sees overturned verdict in state case as incrementally negative for Abbott

Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, which was in favor of Reckitt Benckiser’s (RBGLY) Mead Johnson unit. The jury had originally ruled that Mead Johnson was not liable for failing to warn of the risks of NEC related to its infant formulas. As a reminder, for Abbott (ABT), there is a Federal multidistrict litigation case scheduled for May 5, 2025, in Chicago. The firm anticipates that the case

TipRanks last month

ABT

RBGLY

RBGPF
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.

Investopedia last month

ABT

RBGLY
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor. Reckitt shares fell about 1.7% in London, while Abbott shares dropped 2.4% in U.S. trading. Last October a jury had found the companies were not liable in a state lawsuit that alleged the companies’s infant formula products caused necrotizing enterocolitis, a debilitating intestinal disease that can cause bloating, vomiting and diarrhea in premature babies.

The Wall Street Journal last month

RBGLY

RBGPF

ABT
Trending tickers: Nvidia, Reddit, BP, Reckitt Benckiser

The latest investor updates on stocks that are trending on Monday.

Yahoo Finance UK last month

^FTSE

NVDA

^IXIC
Reckitt still assessing options for Mead Johnson infant-formula “exit”

CEO Kris Licht has clarified that no timeframe has yet been set for an exit from the nutrition business unit.

Just Food last month

RBGLY
Reckitt Benckiser Group (LON:RKT) Will Pay A Larger Dividend Than Last Year At £1.22

Reckitt Benckiser Group plc's ( LON:RKT ) dividend will be increasing from last year's payment of the same period to...

Simply Wall St. last month

RBGLY

RBGPF
Reckitt Benckiser Group PLC (RBGLY) Full Year 2024 Earnings Call Highlights: Strong Profit ...

Reckitt Benckiser Group PLC (RBGLY) reports robust profit growth and shareholder returns despite facing supply disruptions and market challenges in 2024.

GuruFocus.com last month

RBGLY
Reckitt Benckiser Group Full Year 2024 Earnings: EPS Misses Expectations

Reckitt Benckiser Group ( LON:RKT ) Full Year 2024 Results Key Financial Results Revenue: UK£14.2b (down 3.0% from FY...

Simply Wall St. last month

RBGLY

RBGPF
Lysol Maker Reckitt Benckiser Shares Rise After Profit Beat

Adjusted profit of nearly £3.5 billion came in ahead of expectations for 2024 as the consumer-goods company continues to progress with its turnaround plans.

The Wall Street Journal last month

RBGLY

RBGPF
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help

LONDON (Reuters) -Britain's Reckitt Benckiser, the maker of Strepsils throat lozenges and Dettol cleaning products, missed expectations for fourth-quarter like-for-like net sales as a late flu and cold season dented demand for its over-the-counter medicines. Reckitt, whose products include Nurofen tablets, cold remedy Lemsip and Durex condoms, forecast full-year like-for-like net sales growth of 2% to 4%, and that it has so far this year seen a boost from sales in emerging markets India and China. The firm expects low-single digit sales growth in North America in the first quarter of the year, however, as U.S. pharmacies stock fewer products.

Reuters last month

RBGLY
Stocks to watch this week: Broadcom, Costco, JD.com, Adidas and Greggs

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK last month

APAX.L

LCSHF

LCSHY
MS Global Franchise Portfolio Exits Reckitt Benckiser Group PLC with a -2.37% Impact

Exploring the Strategic Moves of MS Global Franchise Portfolio (Trades, Portfolio) in Q4 2024

GuruFocus.com last month

RBGLY

Performance Overview

Return	3RB.SG	FTSE 100 (^FTSE)
YTD	-0.12%	+0.79%
1-Year	+21.25%	+5.34%
3-Year	-14.00%	+8.16%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Reckitt Benckiser Group PLC (3RB.SG)

Reckitt Benckiser Group (LON:RKT shareholders incur further losses as stock declines 9.7% this week, taking five-year losses to 10%

Reckitt Benckiser Group (RBGLY) Upgraded to Strong Buy: Here's What You Should Know

M&A and IPOs Worth Billions Stalled in 24 Hours by Trade War

Are You Looking for a Top Momentum Pick? Why Reckitt Benckiser Group PLC (RBGLY) is a Great Choice

With 84% institutional ownership, Reckitt Benckiser Group plc (LON:RKT) is a favorite amongst the big guns

RFK Jr.’s Next Targets Are Companies Making Baby Formula

Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case

As trade war intensifies, Reckitt may be more exposed than some rivals

Citi sees overturned verdict in state case as incrementally negative for Abbott

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial

Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case

Trending tickers: Nvidia, Reddit, BP, Reckitt Benckiser

Reckitt still assessing options for Mead Johnson infant-formula “exit”

Reckitt Benckiser Group (LON:RKT) Will Pay A Larger Dividend Than Last Year At £1.22

Reckitt Benckiser Group PLC (RBGLY) Full Year 2024 Earnings Call Highlights: Strong Profit ...

Reckitt Benckiser Group Full Year 2024 Earnings: EPS Misses Expectations

Lysol Maker Reckitt Benckiser Shares Rise After Profit Beat

Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help

Stocks to watch this week: Broadcom, Costco, JD.com, Adidas and Greggs

MS Global Franchise Portfolio Exits Reckitt Benckiser Group PLC with a -2.37% Impact

Performance Overview